Organon & Co. logo

Organon & Co. Share Price (NYSE: OGN)

$9.41

-0.01

(-0.11%)

Last updated on

Check the interactive Organon & Co. Stock chart to analyse performance

Organon & Co. stock performance

as on September 3, 2025 at 1:29 am IST

  • Today's Low:$9.16
    Today's High:$9.45

    Day's Volatility :3.07%

  • 52 Weeks Low:$8.01
    52 Weeks High:$22.42

    52 Weeks Volatility :64.27%

Organon & Co. Stock Returns

PeriodOrganon & Co.Sector (Health Care)Index (Russel 2000)
3 Months
-1.15%
3.3%
0.0%
6 Months
-34.81%
-8.1%
0.0%
1 Year
-57.34%
-12.4%
0.0%
3 Years
-67.19%
10.0%
-2.3%

Organon & Co. Key Stats

Check Organon & Co. key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$9.42
Open
$9.35
Today's High
$9.45
Today's Low
$9.16
Market Capitalization
$2.4B
Today's Volume
$4.6M
52 Week High
$22.42
52 Week Low
$8.01
Revenue TTM
$6.3B
EBITDA
$1.7B
Earnings Per Share (EPS)
$2.69
PE Ratio
3.5
Dividend Yield
9.37%
Profit Margin
11.15%
Quarterly Earnings Growth YOY
-0.26%
Return On Equity TTM
159.64%

Stock Returns calculator for Organon & Co. Stock including INR - Dollar returns

The Organon & Co. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Organon & Co. investment value today

Current value as on today

₹47,623

Returns

₹52,377

(-52.38%)

Returns from Organon & Co. Stock

₹57,382 (-57.38%)

Dollar Returns*

₹5,006 (+5.01%)

Indian investors sentiment towards Organon & Co. Stock

-7%

Period: Aug 3, 2025 to Sep 2, 2025. Change in 30 Days versus previous period

Search interest for Organon & Co. Stock from India on INDmoney has decreased by -7% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Organon & Co.

  • Name

    Holdings %

  • Vanguard Group Inc

    12.42%

  • BlackRock Inc

    12.26%

  • Massachusetts Financial Services Company

    3.94%

  • State Street Corp

    3.45%

  • LSV Asset Management

    3.07%

  • Morgan Stanley - Brokerage Accounts

    2.16%

Analyst Recommendation on Organon & Co. Stock

Rating
Trend

Buy

    50%Buy

    42%Hold

    7%Sell

Based on 14 Wall street analysts offering stock ratings for Organon & Co.(by analysts ranked 0 to 5 stars)

Organon & Co. Share Price Target

What analysts predicted

Upside of 39.92%

Target:

$13.17

Current:

$9.41

Organon & Co. share price target is $13.17, a slight Upside of 39.92% compared to current price of $9.41 as per analysts' prediction.

Organon & Co. Stock Insights

  • Price Movement

    In the last 1 year, OGN stock has moved down by -57.3%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 1.51B → 1.59B (in $), with an average increase of 5.1% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, 87.0M → 145.0M (in $), with an average increase of 40.0% per quarter
  • OGN vs ABBV (1 yr)

    In the last 1 year, Abbvie Inc has given 6.4% return, outperforming this stock by 63.7%
  • OGN vs LLY (3 yr)

    In the last 3 years, Eli Lilly And Company has given 54.4% return, outperforming this stock by 121.3%
  • Price to Sales

    ForOGN every $1 of sales, investors are willing to pay $0.4, whereas for Abbvie Inc, the investors are paying $6.4 for every $1 of sales.

Organon & Co. Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$6.4B
↑ 2.24%
Net Income
$864.0M
↓ 15.54%
Net Profit Margin
13.49%
↓ 2.84%

Organon & Co. Technicals Summary

Sell

Neutral

Buy

Organon & Co. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Organon & Co. Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Organon & Co. logo
-2.59%
-34.81%
-57.34%
-67.19%
-73.83%
Eli Lilly And Company logo
-4.74%
-21.2%
-23.41%
138.77%
385.44%
Johnson & Johnson logo
3.58%
7.3%
5.99%
8.57%
19.23%
Merck & Co. Inc. logo
5.33%
-9.73%
-27.84%
-2.66%
-1.31%
Novo Nordisk A/s logo
15.67%
-37.86%
-58.56%
9.01%
73.43%
Abbvie Inc logo
6.7%
-0.54%
6.43%
52.92%
129.02%

Organon & Co. Dividend announcements

  • Organon & Co. Dividends September, 2025

    In the quarter ending September,2025. Organon & Co. has declared dividend of $0.02

About Organon & Co.

Organon & Co. develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally. The company's women's health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; Cerazette, Marvelon, and Mercilon, which are daily pills used to prevent pregnancy; Follistim AQ, which is used to promote the development of multiple ovarian follicles in medically assisted reproduction procedures; Elonva, a follicle stimulant; Ganirelix acetate injection, an injectable antagonist; Jada for abnormal postpartum uterine bleeding or hemorrhage; and Xaciato for bacterial vaginosis. Its biosimilars portfolio consists of immunology products, such as Brenzys, Renflexis, and Hadlima; and two oncology products, including Ontruzant and Aybintio. The company also offers cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Inegy, Atozet, Rosuzet, and Zocor brands; Cozaar and Hyzaar for hypertension; respiratory products used to control and prevent asthma-induced symptoms under the Singulair, Dulera, Zenhale, and Asmanex brands, as well as seasonal allergic rhinitis under the Nasonex, Clarinex, and Aerius brands. In addition, it provides dermatology products under the Vtama, Diprosone, and Elocon brand; bone health products under the Fosamax brand; and non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brands, as well as Proscar for symptomatic benign prostatic hyperplasia; and Propecia for male pattern hair loss. The company sells its products to drug wholesalers and retailers, hospitals, clinics, government agencies, health maintenance organizations, pharmacy benefit managers, and other institutions. Organon & Co. was founded in 1923 and is headquartered in Jersey City, New Jersey.
Organization
Organon & Co.
Employees
10000
CEO
Mr. Kevin Ali
Industry
Healthcare

Key Management of Organon & Co.

NameTitle
Mr. Kevin Ali
CEO & Director
Mr. Matthew M. Walsh C.F.A.
Executive VP & CFO
Mr. Joseph T. Morrissey Jr.
Executive VP and Head of Manufacturing & Supply
Dr. Juan Camilo Arjona Ferreira M.D.
Executive VP, Head of Research & Development and Chief Medical Officer
Ms. Jennifer Halchak
Head of Investor Relations
Mr. Kirke Weaver
Executive VP, General Counsel & Corporate Secretary
Mr. Daniel Karp
Head of Corporate Development
Mr. Aaron Falcione
Executive VP & Chief Human Resources Officer
Mr. Vittorio Nisita
Executive VP & Head of Enterprise Services and Solutions
Ms. Rachel A. Stahler
Chief Digital & Commercial Innovation Officer

Important FAQs about investing in OGN Stock from India :

What is Organon & Co. share price today?

Organon & Co. share price today is $9.41 as on at the close of the market. Organon & Co. share today touched a day high of $9.45 and a low of $9.16.

What is the 52 week high and 52 week low for Organon & Co. share?

Organon & Co. share touched a 52 week high of $22.42 and a 52 week low of $8.01. Organon & Co. stock price today i.e. is closed at $9.41, lower by 58.03% versus the 52 week high.

How to invest in Organon & Co. Stock (OGN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Organon & Co. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Organon & Co. Shares that will get you 0.1594 shares as per Organon & Co. share price of $9.41 per share as on September 3, 2025 at 1:29 am IST.

What is the minimum amount required to buy Organon & Co. Stock (OGN) from India?

Indian investors can start investing in Organon & Co. (OGN) shares with as little as ₹88.16 or $1 (as of September 03, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹881.60 in Organon & Co. stock (as per the Rupee-Dollar exchange rate as on September 03, 2025). Based on Organon & Co. share’s latest price of $9.41 as on September 3, 2025 at 1:29 am IST, you will get 1.0627 shares of Organon & Co.. Learn more about fractional shares .

What are the returns that Organon & Co. has given to Indian investors in the last 5 years?

Organon & Co. stock has given -73.83% share price returns and 20.13% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?

Discover More